{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:55:11Z","timestamp":1793890511709,"version":"4.8.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Dysregulation of both the innate and the adaptive immune systems has been identified in systemic sclerosis (SSc). However, the mechanisms underlying aberrant immune cell function remain poorly understood. T cells represent a predominant cell type in the affected tissues of patients, particularly in the early inflammatory stage of the disease. Antigen specificity of infiltrating T cells has not been identified; however, recent studies implicate specific T-cell subsets and the cytokines they produce in SSc pathogenesis by modulating the development of autoimmunity, inflammation and fibrosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The phenotype and function of distinct T-cell subsets have been identified in the affected tissues of SSc patients as well as in SSc animal models, implying their contribution to disease process. The molecular mechanisms underlying cytokine dysregulation by specific T-cell subpopulations are also becoming clear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>A better understanding of SSc pathogenesis will allow the development of novel therapeutic strategies targeting specific cell types and the pathways that are abnormally activated as well as the cytokines produced that may be directly involved with disease process. A further goal is to tailor therapy to address dysregulation specific to individual patients, leading to better efficacy and reduced toxicity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000553","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T22:05:34Z","timestamp":1537999534000},"page":"594-599","source":"Crossref","is-referenced-by-count":32,"title":["T cells and cytokines in systemic sclerosis"],"prefix":"10.1097","volume":"30","author":[{"given":"Patrizia","family":"Fuschiotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"Immunotargets Ther"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00281-015-0509-1","article-title":"The role of the acquired immune response in systemic sclerosis","volume":"37","author":"Chizzolini","year":"2015","journal-title":"Semin Immunopathol"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.1780200410","article-title":"Cellular infiltrates in scleroderma skin","volume":"20","author":"Fleischmajer","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"Kahari","year":"1988","journal-title":"J Invest Dermatol"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1988.tb01158.x","article-title":"Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization","volume":"18","author":"Scharffetter","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archdermatol.2009.225","article-title":"Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis","volume":"145","author":"Kreuter","year":"2009","journal-title":"Arch Dermatol"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","article-title":"Oligoclonal T cell expansion in the skin of patients with systemic sclerosis","volume":"168","author":"Sakkas","year":"2002","journal-title":"J Immunol"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","article-title":"Regulatory T cells in systemic sclerosis: a comprehensive review","volume":"52","author":"Slobodin","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"e5981","DOI":"10.1371\/journal.pone.0005981","article-title":"Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.40399","article-title":"Increased expression and modulated regulatory activity of coinhibitory receptors PD-1, TIGIT, and TIM-3 in lymphocytes from patients with systemic sclerosis","volume":"70","author":"Fleury","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.05.013","article-title":"Increased proportions of functionally impaired regulatory T cell subsets in systemic sclerosis","volume":"184","author":"Ugor","year":"2017","journal-title":"Clin Immunol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jim.2006.10.008","article-title":"Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells","volume":"319","author":"Hartigan-O\u2019Connor","year":"2007","journal-title":"J Immunol Methods"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/HJH.0b013e328362feb7","article-title":"CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension","volume":"31","author":"Kassan","year":"2013","journal-title":"J Hypertens"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5483\/BMBRep.2011.44.4.217","article-title":"Mechanism of T cell exhaustion in a chronic environment","volume":"44","author":"Jin","year":"2011","journal-title":"BMB Rep"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.40164","article-title":"Contribution of soluble forms of programmed death 1 and programmed death ligand 2 to disease severity and progression in systemic sclerosis","volume":"69","author":"Fukasawa","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/scitranslmed.aaf5307","article-title":"T follicular helper-like cells contribute to skin fibrosis","volume":"10","author":"Taylor","year":"2018","journal-title":"Sci Transl Med"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.20160","article-title":"A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease","volume":"50","author":"Ruzek","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/16717","article-title":"ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28","volume":"397","author":"Hutloff","year":"1999","journal-title":"Nature"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI27727","article-title":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation","volume":"116","author":"Pesce","year":"2006","journal-title":"J Clin Invest"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.autrev.2016.02.020","article-title":"Th9 lymphocytes: a recent history from IL-9 to its potential role in rheumatic diseases","volume":"15","author":"Rojas-Zuleta","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","article-title":"Th9 cells and IL-9 in autoimmune disorders: pathogenesis and therapeutic potentials","volume":"78","author":"Deng","year":"2017","journal-title":"Hum Immunol"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cei.12807","article-title":"Interleukin-9 and T helper type 9 cells in rheumatic diseases","volume":"185","author":"Ciccia","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3899\/jrheum.110268","article-title":"Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis","volume":"38","author":"Yanaba","year":"2011","journal-title":"J Rheumatol"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cei.13009","article-title":"Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients","volume":"190","author":"Guggino","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","article-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review","volume":"16","author":"Lee","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/art.24432","article-title":"Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis","volume":"60","author":"Fuschiotti","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jid.2016.11.037","article-title":"Skin-resident effector memory CD8+CD28- T cells exhibit a profibrotic phenotype in patients with systemic sclerosis","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ajpath.2011.11.024","article-title":"Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets","volume":"180","author":"Greenblatt","year":"2012","journal-title":"Am J Pathol"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J Clin Invest"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/rheumatology\/kev335","article-title":"Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis","volume":"55","author":"Rice","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.imlet.2017.10.002","article-title":"Current perspectives on the role of CD8+ T cells in systemic sclerosis","volume":"195","author":"Fuschiotti","year":"2018","journal-title":"Immunol Lett"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"279ra239","DOI":"10.1126\/scitranslmed.3010302","article-title":"Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells","volume":"7","author":"Watanabe","year":"2015","journal-title":"Sci Transl Med"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.it.2015.05.003","article-title":"Emerging concepts in tissue-resident T cells: lessons from humans","volume":"36","author":"Thome","year":"2015","journal-title":"Trends Immunol"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"269rv261","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/BOR.0000000000000112","article-title":"Endothelial dysfunction in systemic sclerosis","volume":"26","author":"Altorok","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R46-20230901","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"e0130166","DOI":"10.1371\/journal.pone.0130166","article-title":"Systemic sclerosis sera impair angiogenic performance of dermal microvascular endothelial cells: therapeutic implications of cyclophosphamide","volume":"10","author":"Borghini","year":"2015","journal-title":"PLoS One"},{"key":"R48-20230901","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"R49-20230901","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.107.694778","article-title":"Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies","volume":"116","author":"Hur","year":"2007","journal-title":"Circulation"},{"key":"R50-20230901","doi-asserted-by":"crossref","first-page":"e0183102","DOI":"10.1371\/journal.pone.0183102","article-title":"Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis","volume":"12","author":"Manetti","year":"2017","journal-title":"PLoS One"},{"key":"R51-20230901","first-page":"21","article-title":"The importance of the type I interferon system in autoimmunity","volume":"34","author":"Ronnblom","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R52-20230901","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"Ronnblom","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R53-20230901","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R54-20230901","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R55-20230901","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.22382","article-title":"A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists","volume":"56","author":"York","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R56-20230901","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R57-20230901","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-kappaB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R58-20230901","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/1756-185X.13175","article-title":"IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis","volume":"20","author":"Rezaei","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R59-20230901","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/039463201402700420","article-title":"Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese","volume":"27","author":"Wang","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R60-20230901","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijd.12839","article-title":"Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis","volume":"55","author":"Xu","year":"2016","journal-title":"Int J Dermatol"},{"key":"R61-20230901","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/039463201302600220","article-title":"STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population","volume":"26","author":"Yi","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R62-20230901","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jid.2017.12.003","article-title":"Genome-wide DNA methylation analysis in systemic sclerosis reveals hypomethylation of IFN-associated genes in CD4(+) and CD8(+) T cells","volume":"138","author":"Ding","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R63-20230901","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"R64-20230901","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/labinvest.2015.154","article-title":"Canonical Wnt signaling in systemic sclerosis","volume":"96","author":"Bergmann","year":"2016","journal-title":"Lab Invest"},{"key":"R65-20230901","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.onc.1203448","article-title":"Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR involves the I kappa B kinase complex","volume":"19","author":"Gil","year":"2000","journal-title":"Oncogene"},{"key":"R66-20230901","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jir.2010.0076","article-title":"Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity","volume":"31","author":"Haller","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"R67-20230901","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.3279","article-title":"PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection","volume":"16","author":"Zhang","year":"2015","journal-title":"Nat Immunol"},{"key":"R68-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-1396-1_1","article-title":"Evolving mechanistic insights into galectin functions","volume":"1207","author":"Arthur","year":"2015","journal-title":"Methods Mol Biol"},{"key":"R69-20230901","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00281-015-0511-7","article-title":"Cytokines in the immunopathology of systemic sclerosis","volume":"37","author":"Raja","year":"2015","journal-title":"Semin Immunopathol"},{"key":"R70-20230901","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jid.2017.04.035","article-title":"Systemic sclerosis dermal fibroblasts suppress Th1 cytokine production via galectin-9 overproduction due to Fli1 deficiency","volume":"137","author":"Saigusa","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R71-20230901","doi-asserted-by":"crossref","first-page":"F822","DOI":"10.1152\/ajprenal.00294.2013","article-title":"Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice","volume":"306","author":"Zhang","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"R72-20230901","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2009.04.012","article-title":"Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and\/or Th17-mediated skin inflammation","volume":"132","author":"Niwa","year":"2009","journal-title":"Clin Immunol"},{"key":"R73-20230901","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","article-title":"Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1","volume":"16","author":"Akamata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R74-20230901","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin","volume":"163","author":"Kubo","year":"2003","journal-title":"Am J Pathol"},{"key":"R75-20230901","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R76-20230901","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/art.39312","article-title":"Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis","volume":"67","author":"Ichimura","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R77-20230901","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R78-20230901","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/art.30489","article-title":"GATA-3 upregulation in CD8+ T cells is a biomarker of immune dysfunction in systemic sclerosis, resulting in excess IL-13 production","volume":"63","author":"Medsger","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R79-20230901","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2017.10.029","article-title":"14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in TC2 and CD8(+) lymphocytes from patients with scleroderma","volume":"142","author":"Cascio","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R80-20230901","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"R81-20230901","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nri954","article-title":"The lineage decisions of helper T cells","volume":"2","author":"Murphy","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R82-20230901","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (\u2217)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"R83-20230901","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0898-6568(00)00131-5","article-title":"14-3-3 proteins: regulation of subcellular localization by molecular interference","volume":"12","author":"Muslin","year":"2000","journal-title":"Cell Signal"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T01:17:12Z","timestamp":1693531032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201811000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000553","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}